Skip to main content
Top
Published in: Inflammation 3/2014

01-06-2014

Altered Inflammatory Responses to Citrobacter rodentium Infection, but not Bacterial Lipopolysaccharide, in Mice Lacking the Cyp4a10 or Cyp4a14 Genes

Authors: Beatrice A. Nyagode, Ifor R. Williams, Edward T. Morgan

Published in: Inflammation | Issue 3/2014

Login to get access

Abstract

Murine hepatic Cyp4a mRNAs are markedly downregulated during inflammation. Here, we investigated the roles of Cyp4a10 and Cyp4a14 in the response to infection with C. rodentium. Absence of either Cyp4a gene attenuated or abrogated the changes in spleen weight, colon crypt length, hepatic cytokine, and acute phase protein mRNAs, and serum acute phase proteins and cytokines caused by infection. Cyp4a10 / mice on a low-salt diet had a similar hepatic acute phase response as those mice on a high-salt diet, suggesting that hypertension associated with this genotype is not the cause of their altered inflammatory response. In contrast, wild-type, Cyp4a10 −/−, and Cyp4a14 −/− mice showed similar responses to injected LPS. These results implicate Cyp4a10 and Cyp4a14 in the regulation of the host inflammatory response to enteropathogenic bacterial infection but not to acute aseptic inflammation. Understanding the mechanism of this role may lead to novel therapeutic approaches in some inflammatory diseases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hardwick, J.P. 2008. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochemical Pharmacology 75: 2263–2275.PubMedCrossRef Hardwick, J.P. 2008. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochemical Pharmacology 75: 2263–2275.PubMedCrossRef
2.
go back to reference Johnson, E.F., C.N. Palmer, K.J. Griffin, and M.H. Hsu. 1996. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. FASEB Journal 10: 1241–1248.PubMed Johnson, E.F., C.N. Palmer, K.J. Griffin, and M.H. Hsu. 1996. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. FASEB Journal 10: 1241–1248.PubMed
3.
go back to reference Sanders, R.J., R. Ofman, F. Valianpour, S. Kemp, and R.J. Wanders. 2005. Evidence for two enzymatic pathways for omega-oxidation of docosanoic acid in rat liver microsomes. Journal of Lipid Research 46: 1001–1008.PubMedCrossRef Sanders, R.J., R. Ofman, F. Valianpour, S. Kemp, and R.J. Wanders. 2005. Evidence for two enzymatic pathways for omega-oxidation of docosanoic acid in rat liver microsomes. Journal of Lipid Research 46: 1001–1008.PubMedCrossRef
4.
go back to reference Gainer, J.V., A. Bellamine, E.P. Dawson, K.E. Womble, S.W. Grant, Y. Wang, L.A. Cupples, C.Y. Guo, S. Demissie, C.J. O’Donnell, N.J. Brown, M.R. Waterman, and J.H. Capdevila. 2005. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 111: 63–69.PubMedCrossRef Gainer, J.V., A. Bellamine, E.P. Dawson, K.E. Womble, S.W. Grant, Y. Wang, L.A. Cupples, C.Y. Guo, S. Demissie, C.J. O’Donnell, N.J. Brown, M.R. Waterman, and J.H. Capdevila. 2005. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 111: 63–69.PubMedCrossRef
5.
go back to reference Heng, Y.M., C.S. Kuo, P.S. Jones, R. Savory, R.M. Schulz, S.R. Tomlinson, T.J. Gray, and D.R. Bell. 1997. A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans. Biochemical Journal 325(Pt 3): 741–749.PubMedCentralPubMed Heng, Y.M., C.S. Kuo, P.S. Jones, R. Savory, R.M. Schulz, S.R. Tomlinson, T.J. Gray, and D.R. Bell. 1997. A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans. Biochemical Journal 325(Pt 3): 741–749.PubMedCentralPubMed
6.
go back to reference Powell, P.K., I. Wolf, R. Jin, and J.M. Lasker. 1998. Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. Journal of Pharmacology and Experimental Therapeutics 285: 1327–1336.PubMed Powell, P.K., I. Wolf, R. Jin, and J.M. Lasker. 1998. Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. Journal of Pharmacology and Experimental Therapeutics 285: 1327–1336.PubMed
7.
go back to reference Lasker, J.M., W.B. Chen, I. Wolf, B.P. Bloswick, P.D. Wilson, and P.K. Powell. 2000. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. Journal of Biological Chemistry 275: 4118–4126.PubMedCrossRef Lasker, J.M., W.B. Chen, I. Wolf, B.P. Bloswick, P.D. Wilson, and P.K. Powell. 2000. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. Journal of Biological Chemistry 275: 4118–4126.PubMedCrossRef
8.
go back to reference McGiff, J.C., and J. Quilley. 1999. 20-HETE and the kidney: resolution of old problems and new beginnings. American Journal of Physiology 277: R607–R623.PubMed McGiff, J.C., and J. Quilley. 1999. 20-HETE and the kidney: resolution of old problems and new beginnings. American Journal of Physiology 277: R607–R623.PubMed
9.
go back to reference Miyata, N., and R.J. Roman. 2005. Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. Journal of Smooth Muscle Research 41: 175–193.PubMedCrossRef Miyata, N., and R.J. Roman. 2005. Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. Journal of Smooth Muscle Research 41: 175–193.PubMedCrossRef
10.
go back to reference Roman, R.J. 2002. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiological Reviews 82: 131–185.PubMed Roman, R.J. 2002. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiological Reviews 82: 131–185.PubMed
11.
go back to reference Sarkis, A., and R.J. Roman. 2004. Role of cytochrome P450 metabolites of arachidonic acid in hypertension. Current Drug Metabolism 5: 245–256.PubMedCrossRef Sarkis, A., and R.J. Roman. 2004. Role of cytochrome P450 metabolites of arachidonic acid in hypertension. Current Drug Metabolism 5: 245–256.PubMedCrossRef
12.
go back to reference King, L.M., J.V. Gainer, G.L. David, D. Dai, J.A. Goldstein, N.J. Brown, and D.C. Zeldin. 2005. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension. Pharmacogenetics and Genomics 15: 7–13.PubMedCrossRef King, L.M., J.V. Gainer, G.L. David, D. Dai, J.A. Goldstein, N.J. Brown, and D.C. Zeldin. 2005. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension. Pharmacogenetics and Genomics 15: 7–13.PubMedCrossRef
13.
go back to reference Liu, X., J. Wu, H. Liu, G. Lai, and Y. Zhao. 2012. Disturbed ratio of renal 20-HETE/EETs is involved in androgen-induced hypertension in cytochrome P450 4F2 transgenic mice. Gene 505: 352–359.PubMedCrossRef Liu, X., J. Wu, H. Liu, G. Lai, and Y. Zhao. 2012. Disturbed ratio of renal 20-HETE/EETs is involved in androgen-induced hypertension in cytochrome P450 4F2 transgenic mice. Gene 505: 352–359.PubMedCrossRef
14.
go back to reference Athirakul, K., J.A. Bradbury, J.P. Graves, L.M. DeGraff, J. Ma, Y. Zhao, J.F. Couse, R. Quigley, D.R. Harder, X. Zhao, J.D. Imig, T.L. Pedersen, J.W. Newman, B.D. Hammock, A.J. Conley, K.S. Korach, T.M. Coffman, and D.C. Zeldin. 2008. Increased blood pressure in mice lacking cytochrome P450 2J5. FASEB Journal 22: 4096–4108.PubMedCentralPubMedCrossRef Athirakul, K., J.A. Bradbury, J.P. Graves, L.M. DeGraff, J. Ma, Y. Zhao, J.F. Couse, R. Quigley, D.R. Harder, X. Zhao, J.D. Imig, T.L. Pedersen, J.W. Newman, B.D. Hammock, A.J. Conley, K.S. Korach, T.M. Coffman, and D.C. Zeldin. 2008. Increased blood pressure in mice lacking cytochrome P450 2J5. FASEB Journal 22: 4096–4108.PubMedCentralPubMedCrossRef
15.
go back to reference Holla, V.R., F. Adas, J.D. Imig, X. Zhao, E. Price Jr., N. Olsen, W.J. Kovacs, M.A. Magnuson, D.S. Keeney, M.D. Breyer, J.R. Falck, M.R. Waterman, and J.H. Capdevila. 2001. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proceedings of the National Academy of Sciences of the United States of America 98: 5211–5216.PubMedCentralPubMedCrossRef Holla, V.R., F. Adas, J.D. Imig, X. Zhao, E. Price Jr., N. Olsen, W.J. Kovacs, M.A. Magnuson, D.S. Keeney, M.D. Breyer, J.R. Falck, M.R. Waterman, and J.H. Capdevila. 2001. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proceedings of the National Academy of Sciences of the United States of America 98: 5211–5216.PubMedCentralPubMedCrossRef
16.
go back to reference Nakagawa, K., V.R. Holla, Y. Wei, W.H. Wang, A. Gatica, S. Wei, S. Mei, C.M. Miller, D.R. Cha, E. Price Jr., R. Zent, A. Pozzi, M.D. Breyer, Y. Guan, J.R. Falck, M.R. Waterman, and J.H. Capdevila. 2006. Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. Journal of Clinical Investigation 116: 1696–1702.PubMedCentralPubMedCrossRef Nakagawa, K., V.R. Holla, Y. Wei, W.H. Wang, A. Gatica, S. Wei, S. Mei, C.M. Miller, D.R. Cha, E. Price Jr., R. Zent, A. Pozzi, M.D. Breyer, Y. Guan, J.R. Falck, M.R. Waterman, and J.H. Capdevila. 2006. Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. Journal of Clinical Investigation 116: 1696–1702.PubMedCentralPubMedCrossRef
17.
go back to reference Chaluvadi, M.R., R.D. Kinloch, B.A. Nyagode, T.A. Richardson, M.J. Raynor, M. Sherman, L. Antonovic, H.W. Strobel, D.L. Dillehay, and E.T. Morgan. 2009. Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of Citrobacter rodentium. Drug Metabolism and Disposition 37: 366–374.PubMedCentralPubMedCrossRef Chaluvadi, M.R., R.D. Kinloch, B.A. Nyagode, T.A. Richardson, M.J. Raynor, M. Sherman, L. Antonovic, H.W. Strobel, D.L. Dillehay, and E.T. Morgan. 2009. Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of Citrobacter rodentium. Drug Metabolism and Disposition 37: 366–374.PubMedCentralPubMedCrossRef
18.
go back to reference Nyagode, B.A., C.M. Lee, and E.T. Morgan. 2010. Modulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6- and interferon-{gamma}-null mice. Journal of Pharmacology and Experimental Therapeutics 335: 480–488.PubMedCentralPubMedCrossRef Nyagode, B.A., C.M. Lee, and E.T. Morgan. 2010. Modulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6- and interferon-{gamma}-null mice. Journal of Pharmacology and Experimental Therapeutics 335: 480–488.PubMedCentralPubMedCrossRef
19.
go back to reference Richardson, T.A., M. Sherman, L. Antonovic, S.S. Kardar, H.W. Strobel, D. Kalman, and E.T. Morgan. 2006. Hepatic and renal cytochrome p450 gene regulation during Citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice. Drug Metabolism and Disposition 34: 354–360.PubMedCentralPubMed Richardson, T.A., M. Sherman, L. Antonovic, S.S. Kardar, H.W. Strobel, D. Kalman, and E.T. Morgan. 2006. Hepatic and renal cytochrome p450 gene regulation during Citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice. Drug Metabolism and Disposition 34: 354–360.PubMedCentralPubMed
20.
go back to reference Richardson, T.A., and E.T. Morgan. 2005. Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice. Journal of Pharmacology and Experimental Therapeutics 314: 703–709.PubMedCrossRef Richardson, T.A., and E.T. Morgan. 2005. Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice. Journal of Pharmacology and Experimental Therapeutics 314: 703–709.PubMedCrossRef
21.
go back to reference Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.PubMedCrossRef Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.PubMedCrossRef
22.
go back to reference Quigley, R., S. Chakravarty, X. Zhao, J.D. Imig, and J.H. Capdevila. 2009. Increased renal proximal convoluted tubule transport contributes to hypertension in Cyp4a14 knockout mice. Nephron. Physiology 113: 23–28.CrossRef Quigley, R., S. Chakravarty, X. Zhao, J.D. Imig, and J.H. Capdevila. 2009. Increased renal proximal convoluted tubule transport contributes to hypertension in Cyp4a14 knockout mice. Nephron. Physiology 113: 23–28.CrossRef
23.
go back to reference Cray, C., J. Zaias, and N.H. Altman. 2009. Acute phase response in animals: a review. Comparative Medicine 59: 517–526.PubMedCentralPubMed Cray, C., J. Zaias, and N.H. Altman. 2009. Acute phase response in animals: a review. Comparative Medicine 59: 517–526.PubMedCentralPubMed
24.
go back to reference Murata, H., N. Shimada, and M. Yoshioka. 2004. Current research on acute phase proteins in veterinary diagnosis: an overview. Veterinary Journal 168: 28–40.CrossRef Murata, H., N. Shimada, and M. Yoshioka. 2004. Current research on acute phase proteins in veterinary diagnosis: an overview. Veterinary Journal 168: 28–40.CrossRef
25.
go back to reference Kinloch, R.D., C.M. Lee, N. van Rooijen, and E.T. Morgan. 2011. Selective role for tumor necrosis factor-alpha, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen. Biochemical Pharmacology 82: 312–321.PubMedCentralPubMedCrossRef Kinloch, R.D., C.M. Lee, N. van Rooijen, and E.T. Morgan. 2011. Selective role for tumor necrosis factor-alpha, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen. Biochemical Pharmacology 82: 312–321.PubMedCentralPubMedCrossRef
26.
go back to reference Tunctan, B., B. Korkmaz, A.N. Sari, M. Kacan, D. Unsal, M.S. Serin, C.K. Buharalioglu, S. Sahan-Firat, T. Cuez, W.H. Schunck, J.R. Falck, and K.U. Malik. 2013. 5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2/IKKbeta/IkappaB-alpha/NF-kappaB pathway, and proinflammatory cytokine formation. Prostaglandins and Other Lipid Mediators 102–103: 31–41.PubMedCrossRef Tunctan, B., B. Korkmaz, A.N. Sari, M. Kacan, D. Unsal, M.S. Serin, C.K. Buharalioglu, S. Sahan-Firat, T. Cuez, W.H. Schunck, J.R. Falck, and K.U. Malik. 2013. 5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2/IKKbeta/IkappaB-alpha/NF-kappaB pathway, and proinflammatory cytokine formation. Prostaglandins and Other Lipid Mediators 102–103: 31–41.PubMedCrossRef
27.
go back to reference Ng, V.Y., Y. Huang, L.M. Reddy, J.R. Falck, E.T. Lin, and D.L. Kroetz. 2007. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha. Drug Metabolism and Disposition 35: 1126–1134.PubMedCrossRef Ng, V.Y., Y. Huang, L.M. Reddy, J.R. Falck, E.T. Lin, and D.L. Kroetz. 2007. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha. Drug Metabolism and Disposition 35: 1126–1134.PubMedCrossRef
28.
go back to reference Delerive, P., K. De Bosscher, S. Besnard, W. Vanden Berghe, J.M. Peters, F.J. Gonzalez, J.C. Fruchart, A. Tedgui, G. Haegeman, and B. Staels. 1999. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. Journal of Biological Chemistry 274: 32048–32054.PubMedCrossRef Delerive, P., K. De Bosscher, S. Besnard, W. Vanden Berghe, J.M. Peters, F.J. Gonzalez, J.C. Fruchart, A. Tedgui, G. Haegeman, and B. Staels. 1999. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. Journal of Biological Chemistry 274: 32048–32054.PubMedCrossRef
29.
go back to reference Muller, D.N., C. Schmidt, E. Barbosa-Sicard, M. Wellner, V. Gross, H. Hercule, M. Markovic, H. Honeck, F.C. Luft, and W.H. Schunck. 2007. Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation. Biochemical Journal 403: 109–118.PubMedCentralPubMedCrossRef Muller, D.N., C. Schmidt, E. Barbosa-Sicard, M. Wellner, V. Gross, H. Hercule, M. Markovic, H. Honeck, F.C. Luft, and W.H. Schunck. 2007. Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation. Biochemical Journal 403: 109–118.PubMedCentralPubMedCrossRef
30.
go back to reference Dierks, E.A., S.C. Davis, and P.R. Ortiz de Montellano. 1998. Glu-320 and Asp-323 are determinants of the CYP4A1 hydroxylation regiospecificity and resistance to inactivation by 1-aminobenzotriazole. Biochemistry 37: 1839–1847.PubMedCrossRef Dierks, E.A., S.C. Davis, and P.R. Ortiz de Montellano. 1998. Glu-320 and Asp-323 are determinants of the CYP4A1 hydroxylation regiospecificity and resistance to inactivation by 1-aminobenzotriazole. Biochemistry 37: 1839–1847.PubMedCrossRef
31.
go back to reference Xu, Z., L. Chen, L. Leung, T.S. Yen, C. Lee, and J.Y. Chan. 2005. Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proceedings of the National Academy of Sciences of the United States of America 102: 4120–4125.PubMedCentralPubMedCrossRef Xu, Z., L. Chen, L. Leung, T.S. Yen, C. Lee, and J.Y. Chan. 2005. Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proceedings of the National Academy of Sciences of the United States of America 102: 4120–4125.PubMedCentralPubMedCrossRef
32.
go back to reference Christmas, P., K. Tolentino, V. Primo, K.Z. Berry, R.C. Murphy, M. Chen, D.M. Lee, and R.J. Soberman. 2006. Cytochrome P-450 4F18 is the leukotriene B4 omega-1/omega-2 hydroxylase in mouse polymorphonuclear leukocytes: identification as the functional orthologue of human polymorphonuclear leukocyte CYP4F3A in the down-regulation of responses to LTB4. Journal of Biological Chemistry 281: 7189–7196.PubMedCrossRef Christmas, P., K. Tolentino, V. Primo, K.Z. Berry, R.C. Murphy, M. Chen, D.M. Lee, and R.J. Soberman. 2006. Cytochrome P-450 4F18 is the leukotriene B4 omega-1/omega-2 hydroxylase in mouse polymorphonuclear leukocytes: identification as the functional orthologue of human polymorphonuclear leukocyte CYP4F3A in the down-regulation of responses to LTB4. Journal of Biological Chemistry 281: 7189–7196.PubMedCrossRef
33.
go back to reference Lee, S.S., T. Pineau, J. Drago, E.J. Lee, J.W. Owens, D.L. Kroetz, P.M. Fernandez-Salguero, H. Westphal, and F.J. Gonzalez. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Molecular and Cellular Biology 15: 3012–3022.PubMedCentralPubMed Lee, S.S., T. Pineau, J. Drago, E.J. Lee, J.W. Owens, D.L. Kroetz, P.M. Fernandez-Salguero, H. Westphal, and F.J. Gonzalez. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Molecular and Cellular Biology 15: 3012–3022.PubMedCentralPubMed
34.
go back to reference Barclay, T.B., J.M. Peters, M.B. Sewer, L. Ferrari, F.J. Gonzalez, and E.T. Morgan. 1999. Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent. Journal of Pharmacology and Experimental Therapeutics 290: 1250–1257.PubMed Barclay, T.B., J.M. Peters, M.B. Sewer, L. Ferrari, F.J. Gonzalez, and E.T. Morgan. 1999. Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent. Journal of Pharmacology and Experimental Therapeutics 290: 1250–1257.PubMed
35.
go back to reference Pan, J., Q. Xiang, S. Ball, J. Scatina, J. Kao, and J.Y. Hong. 2003. Lipopolysaccharide-mediated modulation of cytochromes P450 in Stat1 null mice. Drug Metabolism and Disposition 31: 392–397.PubMedCrossRef Pan, J., Q. Xiang, S. Ball, J. Scatina, J. Kao, and J.Y. Hong. 2003. Lipopolysaccharide-mediated modulation of cytochromes P450 in Stat1 null mice. Drug Metabolism and Disposition 31: 392–397.PubMedCrossRef
Metadata
Title
Altered Inflammatory Responses to Citrobacter rodentium Infection, but not Bacterial Lipopolysaccharide, in Mice Lacking the Cyp4a10 or Cyp4a14 Genes
Authors
Beatrice A. Nyagode
Ifor R. Williams
Edward T. Morgan
Publication date
01-06-2014
Publisher
Springer US
Published in
Inflammation / Issue 3/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9809-6

Other articles of this Issue 3/2014

Inflammation 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.